Montage Resources Corp (NYSE:MR) Given $7.00 Average Price Target by Analysts
Montage Resources Corp (NYSE:MR) has received a consensus broker rating score of 3.00 (Hold) from the four brokers that cover the company, Zacks Investment Research reports. Four analysts have rated the stock with a hold rating. Montage Resources’ rating score has declined by 20% in the last three months as a result of a number of analysts’ upgrades and downgrades.
Brokerages have set a 12 month consensus price target of $7.00 for the company and are expecting that the company will post $0.16 earnings per share for the current quarter, according to Zacks. Zacks has also assigned Montage Resources an industry rank of 194 out of 256 based on the ratings given to related companies.
A number of equities research analysts have commented on the stock. Zacks Investment Research raised shares of Montage Resources from a “hold” rating to a “buy” rating and set a $3.25 price objective on the stock in a report on Wednesday, August 28th. Royal Bank of Canada set a $17.00 target price on shares of Montage Resources and gave the company a “buy” rating in a research report on Friday, August 9th. Finally, Imperial Capital cut their target price on shares of Montage Resources from $9.00 to $6.00 and set an “inline” rating on the stock in a research report on Wednesday, July 10th.
Montage Resources (NYSE:MR) last issued its quarterly earnings data on Tuesday, August 6th. The medical instruments supplier reported $0.41 EPS for the quarter, topping analysts’ consensus estimates of ($0.03) by $0.44. Montage Resources had a net margin of 9.01% and a return on equity of 9.50%. The firm had revenue of $155.54 million for the quarter, compared to analyst estimates of $145.23 million. On average, equities research analysts anticipate that Montage Resources will post 1.65 EPS for the current fiscal year.
A number of institutional investors have recently added to or reduced their stakes in the business. ClariVest Asset Management LLC acquired a new stake in shares of Montage Resources in the 2nd quarter valued at approximately $347,000. UBS Asset Management Americas Inc. acquired a new stake in shares of Montage Resources in the 2nd quarter valued at approximately $61,000. D. E. Shaw & Co. Inc. raised its position in shares of Montage Resources by 171.6% in the 2nd quarter. D. E. Shaw & Co. Inc. now owns 275,148 shares of the medical instruments supplier’s stock valued at $1,678,000 after acquiring an additional 173,857 shares during the period. Point72 Hong Kong Ltd raised its position in shares of Montage Resources by 322.9% in the 2nd quarter. Point72 Hong Kong Ltd now owns 5,003 shares of the medical instruments supplier’s stock valued at $31,000 after acquiring an additional 3,820 shares during the period. Finally, Cubist Systematic Strategies LLC raised its position in shares of Montage Resources by 93.8% in the 2nd quarter. Cubist Systematic Strategies LLC now owns 22,549 shares of the medical instruments supplier’s stock valued at $138,000 after acquiring an additional 10,915 shares during the period. Institutional investors own 76.59% of the company’s stock.
Montage Resources Company Profile
Montage Resources Corporation operates as an oil and natural gas exploration and production company. As of December 31, 2018, it had an acreage position comprising approximately 241,000 net acres in Ohio and Pennsylvania; and had estimated proved reserves of 1,864.7 billion cubic feet of natural gas equivalent.
Featured Story: What is a closed-end mutual fund (CEF)?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Montage Resources Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Montage Resources and related companies with MarketBeat.com's FREE daily email newsletter.